Hopes and concerns regarding the implementation of expanded access protocols in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Hopes and concerns regarding the implementation of expanded access protocols in amyotrophic lateral sclerosis

Published:2023-04-10 Issue:6 Volume:67 Page:433-435
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Lee Ikjae¹^ORCID,Simmons Zachary²^ORCID

Affiliation:

1. Department of Neurology Columbia University Irving Medical Center New York New York USA

2. Department of Neurology Penn State College of Medicine Hershey Pennsylvania USA

Abstract

See article on pages 456–463 in this issue.

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27828

Reference19 articles.

1. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

2. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

3. Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

4. Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)

5. FDA Releases Action Plan for Rare Neurodegenerative Diseases Including ALS U.S. FOOD & DRUG ADMINSTRATION website https://www.fda.gov/news-events/press-announcements/fda-releases-action-plan-rare-neurodegenerative-diseases-including-als updated June 23 2022. Accessed March 28 2023.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis;Muscle & Nerve;2024-06-06